FindTrial
Sign In

Study on the Mechanism and Targeted Intervention of miR-3064-5p/RBM10/JAK/STAT Axis in Regulating Proliferation of Non-Small Cell Lung Cancer

Study on the Mechanism and Targeted Intervention of miR-3064-5p/RBM10/JAK/STAT Axis in Regulating Proliferation of Non-Small Cell Lung Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121248
Enrollment
Unknown
Registered
2026-03-27
Start date
2026-03-27
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Lung Cancer Group:None

Sponsors

Sun Yat-sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Pleural effusion pathology or pleural biopsy suggests NSCLC. 2. There are measurable lesions in the lungs. 3. No drugs have been injected into the thoracic cavity within the past month; 4. No other serious diseases of the heart, liver, kidneys or hematopoietic system, pregnant women and children with mental disorders, and no immune system diseases.

Exclusion criteria

Exclusion criteria: 1.Those who refuse to participate in the research, have severe neuropsychiatric disorders, or have severe heart and lung diseases, and are determined by medical staff to be unable to participate in the follow-up process.

Design outcomes

Primary

MeasureTime frame
RBM10 gene mutation ;the expression of RBM10 protein;—

Countries

China

Contacts

Public ContactMa jiangjun

Sun Yat-sen University Cancer Center

majj@sysucc.org.cn+86 20 8734 1134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026